| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $-0.78 (Miss by $-0.26) |
| EPS GAAP Actual | $-0.78 (Miss by $-0.26) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.345 |
| EPS GAAP Estimate | $-0.345 |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.32333 | 12.99 | 1.32333 | 1.32333 | 2 |
| Dec 2028 | 1.238 | 13.89 | 1.238 | 1.238 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.78 | -0.42 | 0B | NAN% | 0M |
| FQ2 2025 (Jun 2025) | -0.5 | -0.1425 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -0.27 | 0.085 | 0B | NAN% | 0M |
| FQ4 2024 (Dec 2024) | -0.41 | -0.101 | 0B | NAN% | 0M |
| FQ4 2016 (Nov 2016) | -2.05 | -2.05 | 0B | NAN% | 0M |
| FQ1 2017 (Feb 2017) | -1.35 | -1.35 | 0B | NAN% | 0M |
| FQ2 2017 (May 2017) | -1.75 | -1.75 | 0B | NAN% | 0M |
| FQ3 2017 (Aug 2017) | -1.67 | -1.67 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.345
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.57 | -- | -0.57 | -0.57 | 1 |
| FQ3 2027 (Sep 2027) | -0.57 | -- | -0.57 | -0.57 | 1 |
| FQ2 2027 (Jun 2027) | -0.55 | -- | -0.55 | -0.55 | 1 |
| FQ1 2027 (Mar 2027) | -0.54 | -- | -0.54 | -0.54 | 1 |
| FQ4 2026 (Dec 2026) | -0.38 | -- | -0.38 | -0.38 | 1 |
| FQ3 2026 (Sep 2026) | -0.365 | -113.7 | -0.365 | -0.365 | 1 |
| FQ2 2026 (Jun 2026) | -0.35 | -42.86 | -0.35 | -0.35 | 1 |
| FQ1 2026 (Mar 2026) | -0.345 | 21.74 | -0.345 | -0.345 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0B | -- | 0B | 0B | 0 |
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 0 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 0 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 0 |
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 0 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 |
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 |
| FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.36 | -0.78 | -0.42 | 53.85% |
| FQ2 2025 (Jun 2025) | -0.3575 | -0.5 | -0.1425 | 28.5% |
| FQ1 2025 (Mar 2025) | -0.355 | -0.27 | 0.085 | -31.48% |
| FQ4 2024 (Dec 2024) | -0.309 | -0.41 | -0.101 | 24.63% |
| FQ4 2016 (Nov 2016) | -2.05 | -2.05 | 100% | |
| FQ1 2017 (Feb 2017) | -1.35 | -1.35 | 100% | |
| FQ2 2017 (May 2017) | -1.75 | -1.75 | 100% | |
| FQ3 2017 (Aug 2017) | -1.67 | -1.67 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2016 (Nov 2016) | $0B | $0B | $0M | NAN% |
| FQ1 2017 (Feb 2017) | $0B | $0B | $0M | NAN% |
| FQ2 2017 (May 2017) | $0B | $0B | $0M | NAN% |
| FQ3 2017 (Aug 2017) | $0B | $0B | $0M | NAN% |